HDAC9 and cancer: In this present research, the curcumin derivative CU17 with 2-aminothiophenol (Figure 1) was chosen for further studies on its HDAC inhibitory and anti-cancer activities against the NSCLC cell line because it presented the least toxicity to non-cancer cells (Vero cells) and great efficiency of anti-proliferative activity against several cancer cell lines [21].